OTC Triptans in Sweden

April 2013 | 24 pages | ID: O12400A6692EN
Euromonitor International Ltd

Abstracts

The most likely customer of OTC triptans products in Sweden suffers from migraines but has not been diagnosed by a medical professional. The growing self-medication trend is therefore a key driver of sales and value growth in 2012.

Euromonitor International's OTC Triptans in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the OTC Triptans market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

OTC TRIPTANS IN SWEDEN
Euromonitor International
April 2013

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of OTC Triptans: Value 2008-2012
  Table 2 Sales of OTC Triptans: % Value Growth 2008-2012
  Table 3 OTC Triptans Company Shares by Value 2008-2012
  Table 4 OTC Triptans Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of OTC Triptans: Value 2012-2017
  Table 6 Forecast Sales of OTC Triptans: % Value Growth 2012-2017
Executive Summary
Positive Value Growth for Consumer Health
Self-medication Trend Is A Key Theme
Multinationals Dominate in A Competitive Environment
Chemists/pharmacies Still Dominate Shifting Distribution Landscape
Continued Value Growth Expected
Key Trends and Developments
Deregulation Sparks Heated Debate
Rapid Slowdown in the Swedish Economy
the Impact of the Ageing Population
Increased Competition Means Hard Times for Pharmacy Retailers
Self-medication Drives Value Growth
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
European Regulatory Systems
Marketing Authorisations
Advertising
Standardised Packaging Requirements
Vitamins and Dietary Supplements Registration and Classification
Distribution
Regulation of Vitamins and Dietary Supplements
Regulation of Herbal Products
Advertising
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2010-2012
Definitions
Sources
Summary 2 Research Sources